
ASHPOfficial is the premier podcast of ASHP and the collective voice of our 50,000 members in health-system pharmacy. Through interviews and discussions with pharmacy thought leaders, ASHPOfficial will explore issues related to public health, medication use, and supporting the professional practice of pharmacists in hospitals, health systems, ambulatory clinics, and other settings. To learn more about ASHP, please visit ashp.org.
Episodes

Saturday Apr 29, 2023
Therapeutic Thursdays: Ketamine Use in Pediatrics (C.E.)
Saturday Apr 29, 2023
Saturday Apr 29, 2023
This podcast will aim to review various indications of ketamine use within the pediatric population. Relevant dosing, adverse effects, and contraindications will be discussed. Listeners will become familiar with appropriate monitoring parameters to safely use ketamine for pediatrics.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Friday Apr 28, 2023
Friday Apr 28, 2023
In this podcast, expert faculty discuss the answers to questions that pharmacists may receive about the management of atopic dermatitis.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Thursday Apr 27, 2023
Thursday Apr 27, 2023
In this episode, our presenters at the 2022 Midyear Clinical Meeting review the signs and symptoms of Monkey Pox along with the current pharmacological options for treatment.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Wednesday Apr 26, 2023
Wednesday Apr 26, 2023
In this episode, anesthesia and pharmacy leaders explore the potential impact of implementing radio frequency identification technology on patient and medication safety in care settings where sedation is administered. This ASHP Foundation podcast is part of an initiative supported by Fresenius Kabi.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Friday Apr 21, 2023
Friday Apr 21, 2023
This podcast will review key concepts of pain management in patients with cancer, as well as key findings on drug interactions between various pain medications and immunotherapy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Thursday Apr 20, 2023
Practice Journeys: Career Pearls for Students: Critical Care
Thursday Apr 20, 2023
Thursday Apr 20, 2023
Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Wednesday Apr 19, 2023
Wednesday Apr 19, 2023
This podcast will explore the recent advancements in community pharmacy practice in the northwest and their implementation into practice. Discussions will include independent prescribing, test-treat protocols, preventative health services, disease state management, and the medical billing necessary to sustain these services.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Saturday Apr 15, 2023
Saturday Apr 15, 2023
Major Depressive Disorder (MDD) is common psychiatric condition that causes significant disability and disease burden. Treatment for this condition may require multiple medication trials. Up to thirty percent of individuals with MDD do not receive adequate benefit from several antidepressant drug trials and are considered treatment resistant. The management of treatment resistant depression (TRD) often requires novel approaches. One such approach is to use N-methyl-D-aspartate (NMDA) receptor antagonists such as ketamine or esketamine. This session will review the use of ketamine and esketamine for TRD.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Friday Apr 14, 2023
Friday Apr 14, 2023
In this podcast, expert faculty discuss the answers to questions that pharmacists may receive about the management of alopecia areata.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Thursday Apr 13, 2023
Thursday Apr 13, 2023
In this feature from the 2022 Midyear Clinical Meeting, our content matter experts share updates to the NIOSH guidance and practical implications surrounding USP 800.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.